Next Article in Journal
Integrating Pediatric Hypnosis with Complementary Modalities: Clinical Perspectives on Personalized Treatment
Next Article in Special Issue
High-Risk Neuroblastoma Treatment Review
Previous Article in Journal
Correlates of the Timely Initiation of Complementary Feeding among Children Aged 6–23 Months in Rupandehi District, Nepal

Late Effects and Survivorship Issues in Patients with Neuroblastoma

Department of Pediatrics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
Department of Pediatrics, Weill Cornell Medical College, New York, NY 10065, USA
Department of Pediatrics, Comer Children’s Hospital, University of Chicago, Chicago, IL 60637, USA
Author to whom correspondence should be addressed.
Children 2018, 5(8), 107;
Received: 29 June 2018 / Revised: 27 July 2018 / Accepted: 1 August 2018 / Published: 6 August 2018
(This article belongs to the Special Issue Recent Advances in Diagnosis and Treatment of Neuroblastoma)
Over the past two decades, marked progress has been made in understanding the biology of neuroblastoma; this has led to refined risk stratification and treatment modifications with resultant increasing 5-year survival rates for children with neuroblastoma. Survivors, however, remain at risk for a wide variety of potential treatment-related complications, or “late effects”, which may lead to excess morbidity and premature mortality in this cohort. This review summarizes the existing survivorship literature on long-term health outcomes for survivors of neuroblastoma, focusing specifically on potential injury to the endocrine, sensory, cardiovascular, pulmonary, and renal systems, as well as survivors’ treatment-related risk for subsequent neoplasms and impaired quality of life. Additional work is needed to assess the potential late effects of newer multimodality therapies with the aim of optimizing long-term medical and psychosocial outcomes for all survivors of neuroblastoma. View Full-Text
Keywords: neuroblastoma; late effects; childhood cancer; survivorship neuroblastoma; late effects; childhood cancer; survivorship
Show Figures

Figure 1

MDPI and ACS Style

Friedman, D.N.; Henderson, T.O. Late Effects and Survivorship Issues in Patients with Neuroblastoma. Children 2018, 5, 107.

AMA Style

Friedman DN, Henderson TO. Late Effects and Survivorship Issues in Patients with Neuroblastoma. Children. 2018; 5(8):107.

Chicago/Turabian Style

Friedman, Danielle Novetsky, and Tara O. Henderson. 2018. "Late Effects and Survivorship Issues in Patients with Neuroblastoma" Children 5, no. 8: 107.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop